Metropolitan/nonmetropolitan differences of the impact of COVID‐19 on cancer survivors' care

Whitney E. Zahnd; Jason T. Semprini; Robin C. Vanderpool; Sarah H. Nash; Erin L. Van Blarigan; Mindy C. DeRouen; Angela L. W. Meisner; Chuck Wiggins

doi:10.1111/jrh.70061

Back

Metropolitan/nonmetropolitan differences of the impact of COVID‐19 on cancer survivors' care

Journal article

Open access

Peer reviewed

Metropolitan/nonmetropolitan differences of the impact of COVID‐19 on cancer survivors' care

Whitney E. Zahnd, Jason T. Semprini, Robin C. Vanderpool, Sarah H. Nash, Erin L. Van Blarigan, Mindy C. DeRouen, Angela L. W. Meisner and Chuck Wiggins

The Journal of rural health, Vol.41(3), e70061

01/01/2025

DOI: 10.1111/jrh.70061

PMCID: PMC12311322

PMID: 40977584

Appears in UI Libraries Support Open Access

Files and links (1)

url

https://doi.org/10.1111/jrh.70061View

Published (Version of record) Open Access

Abstract

Purpose To evaluate pandemic-related changes in cancer-related care for cancer survivors residing in nonmetropolitan and metropolitan areas. Methods We used data from the Health Information National Trends-Surveillance Epidemiology End Results (HINTS-SEER) survey administered to cancer survivors from the Greater San Francisco Bay Area, Iowa, and New Mexico between January and August 2021. Respondents were queried on changes to their cancer-related care, including treatment, follow-up appointments, and routine cancer screening/preventive care. We calculated weighted percentages and Rao-Scott chi-square tests for reported differences between nonmetropolitan and metropolitan areas. Findings Compared to survivors residing in metropolitan areas, a higher proportion of those in nonmetropolitan areas reported that their cancer treatment or follow-up appointments were unaffected by the pandemic (38.6% vs 28.1%; P = .008). Survivors in metropolitan areas experienced more of a shift in cancer treatment or follow-up appointments to telehealth (12.5% vs 5.7%, P = .003), but there was no difference in appointment cancellations. More survivors residing in metropolitan versus nonmetropolitan areas reported shifts to telehealth for preventive care (8.2% vs 2.9%, P = .005). There was no difference across nonmetropolitan and metropolitan survivors reporting that cancer-related care was cancelled, that routine cancer screening or preventive care was unaffected by the pandemic, or that providers discussed COVID-19 risks. Conclusions Survivors in nonmetropolitan compared to metropolitan areas had less perceived change in cancer follow-up and treatment schedules. It will be important to assess whether shifts in follow-up and preventive care to telehealth for cancer survivors in need of care during the COVID-19 pandemic affect their long-term outcomes.

Brief Report

UIOWA OA Agreement

Details

Title: Subtitle: Metropolitan/nonmetropolitan differences of the impact of COVID‐19 on cancer survivors' care
Creators: Whitney E. Zahnd - University of Iowa
Jason T. Semprini - Des Moines University
Robin C. Vanderpool - National Cancer Institute
Sarah H. Nash - University of Iowa
Erin L. Van Blarigan - University of California, San Francisco
Mindy C. DeRouen - University of California System
Angela L. W. Meisner - University of New Mexico
Chuck Wiggins - New Mexico Cancer Center
Resource Type: Journal article
Publication Details: The Journal of rural health, Vol.41(3), e70061
DOI: 10.1111/jrh.70061
PMID: 40977584
PMCID: PMC12311322
NLM abbreviation: J Rural Health
ISSN: 0890-765X
eISSN: 1748-0361
Publisher: Wiley
Grant note: HHSN261201800032I / ; ; 1 NU58DP007156; 1 NU58DP007156; 1 NU58DP007156; 1 NU58DP007156; 1 NU58DP007156 / ; HHSN261201800002B; 3P30 CA086862 / ;
Language: English
Date published: 01/01/2025
Academic Unit: Health Management and Policy; Epidemiology; Center for Social Science Innovation; Community and Behavioral Health
Record Identifier: 9984927215902771

Metrics

5 Record Views